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Abstract
Bone morphogenetic protein (BMP) signaling is important for
correct lung morphogenesis, and there is evidence of BMP signaling
reactivation in lung diseases. However, little is known about BMP
signaling patterns in healthy airway homeostasis and inflammatory
airway disease and during epithelial repair. In this study, a rhesus
macaque (Macacamulatta)model of allergic airway disease was used
to investigate BMP signaling throughout the airways in health,
disease, and regeneration. Stereologic quantification of
immunofluorescent images was used to determine the expression of
BMP receptor (BMPR) Ia and phosphorylated SMAD (pSMAD)
1/5/8 in the airway epithelium. A pSMAD 1/5/8 expression gradient
was found along the airways of healthy juvenile rhesus macaques
(n = 3, P, 0.005).Membrane-localized BMPRIa expressionwas also
present in the epithelium of the healthy animals. After exposure to
house dust mite allergen and ozone, significant down-regulation of
nuclear pSMAD 1/5/8 occurs in the epithelium. When the animals
were provided with a recovery period in filtered air, proliferating cell
nuclear antigen, pSMAD 1/5/8, and membrane-localized BMPRIa
expression were significantly increased in the epithelium of
conducting airways (P, 0.005). Furthermore, in the asthmatic
airways, altered BMPRIa localization was evident. Because of the
elevated eosinophil presence in these airways, we investigated the
effect of eosinophil-derived proteins on BMPRIa trafficking in
epithelial cells. Eosinophil-derived proteins (eosinophil-derived
neurotoxin, eosinophil peroxidase, andmajor basic protein) induced
transient nuclear translocation of membrane-bound BMPRIa. This
work mapping SMAD signaling in the airways of nonhuman
primates highlights a potential mechanistic relationship between
inflammatory mediators and BMP signaling and provides evidence
that basal expression of the BMP signaling pathway may be
important for maintaining healthy airways.
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Clinical Relevance
Bone morphogenetic protein (BMP) signaling is essential for
correct lung morphogenesis, and the pathway becomes
reactivated in inflammatory and fibrotic lung diseases.
Whether and how BMP signaling is involved in airway
homeostasis is poorly understood. Here, we investigate BMP
signaling in a nonhuman primate model of allergic airway
disease. Our results indicate that BMP signaling is involved in
epithelial homeostasis and is altered throughout the airways in
asthma and during recovery. Accompanying in vitro studies
highlight a mechanistic relationship involving eosinophil-
induced trafficking of BMP receptor Ia in airway epithelial
cells. This study highlights an important role of BMP signaling
in both healthy and asthmatic airways during inflammation
and repair.
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Both the architecture of the lungs and the
epithelial cell types that line the lungs
change throughout the descending
respiratory tract to reflect specialized
functions therein. The trachea and bronchi
are lined with ciliated and secretory cells in
the form of a pseudostratified epithelium
to facilitate the mucociliary escalator and
the clearance of inhaled pathogens. At
the terminal end of the bronchioles, a single
layer of alveolar epithelial cells type I and
type II line the alveolar sacs. These cells
facilitate the bidirectional movement of
gases between the airways and the blood (1).
Basal cells are differentially distributed
along the proximal-distal axis with a higher
frequency found in the upper airways
(2). In addition, distinct niches populated
with epithelial cell progenitors, such as
the bronchioalveolar stem cell and alveolar
surfactant protein-C-negative progenitors
of the distal airways, are found in the
respiratory tract (3, 4).
It is known that the morphology of
the developing respiratory tract and the
distribution of cell phenotypes throughout
the developing airways are tightly controlled
by signaling molecules, growth factors,
and morphogens. Fibroblast growth
factors, Wnt-b-catenin, Notch, and
bone morphogenetic proteins (BMPs)
produced by the developing endoderm
and underlying mesoderm form a
complex signaling network coordinating
these developmental processes (5). These
signaling factors communicate across the
epithelial-mesenchymal-trophic unit, which
is made up of opposing layers of epithelial
and mesenchymal cells encompassing
a network of basement membrane,
fibroblasts, nerves, and endothelial cells (6).
In adult lungs, the epithelial-mesenchymal-
trophic unit is challenged constantly by
irritants, pathogens, and disease-causing
agents. It is believed that the signaling
factors governing lung morphogenesis are
reactivated after an injury. This causes the
lung epithelium to initiate proliferation and
the differentiation pathways to correctly
restore epithelial integrity. However, in
situations of chronic injury or prolonged
inflammation, the epithelium will
likely undergo incorrect repair, such as
abnormal epithelial cell differentiation
and remodeling events. Although both
normal repair and abnormal disease
processes have been studied extensively, the
underlying signaling processes governing
lung phenotypic changes, remodeling,
inflammation, and restitution of epithelial
homeostasis remain unclear (7, 8).
Previous studies have shown that
BMP signaling is essential for correct
lung formation during embryogenesis,
governing the pattern of lung bud formation
and epithelial cell distribution along
the proximal distal axis (9–11). Studies
inhibiting the BMP pathway using
antagonists, reporter genes, and dominant-
negative overexpression systems in mice
have highlighted the important role this
specific family of patterning molecules
plays in both lung bud morphogenesis
and epithelial cell distribution along the
proximal distal axis. BMP signaling is
also perturbed in airway diseases such as
cancer and pulmonary hypertension
(12, 13). Increased understanding of the
cross talk between BMP and other
developmental signaling pathways has
led to the successful induction of epithelial
cell differentiation from progenitor cells
and dedifferentiation of committed
epithelial cells to stem cells, and BMP
signaling plays a key role in this plastic
process. Furthermore, inhibition of BMP,
Wnt, and transforming growth factor-b
pathways in definitive endoderm cells
followed by the supply of a ventralizing
cocktail containing BMP-4 and other
growth factors is essential for correct
lung specification in vitro (14). These
studies demonstrate that targeted
manipulation of the signaling pathways
governing lung morphogenesis holds
significant potential for regenerative
medicine approaches and highlight BMP
as a key morphogen involved in lung bud
formation and epithelial cell patterning
(15, 16).
We are interested in the concept of
signaling gradients throughout the airways
and the ways in which these may relate to
homeostasis, repair, regeneration, and
inflammatory disease. Seminal studies in
the past have revealed cross talk between
the mesoderm and the developing lung
endoderm and have demonstrated that
the mesenchymal signals contributing to
correct epithelial cell differentiation and
airway branching are spatially regulated.
These studies showed that when tracheal
and distal mesenchyme were transplanted
onto opposing denuded airway regions,
branching morphogenesis and epithelial
cell expansion were altered (17–19). It
is now widely accepted that expression
gradients of morphogens and signaling
components exist along the proximal-distal
axis in the developing airways, as evidenced
by the Sox-2/Sox-9 expression patterns
that exist during development (20).
Furthermore, BMP-4 and fibroblast growth
factor 10 in the mesoderm of the distal
bud tip regulate branching morphogenesis,
whereas reduced concentrations of these
factors are present in more proximal
airway regions (9, 11, 21). A recent study
investigating the development of the
vertebrate mucociliated epithelium
provides further evidence of BMP gradients
in the airways (22). Although gradients
are clearly important during airway
development, little is known about localized
expression profiles and the effects of
morphogen gradients in healthy, fully
developed airways and during fibrotic or
inflammatory diseases.
We hypothesized that a BMP signaling
gradient exists in healthy adult airways
and that this gradient may be altered
during inflammatory airway disease and
regeneration. To investigate this, we examined
the expression pattern of certain BMP
signaling pathway components in healthy
rhesus macaques airways compared with
an allergic airway disease model in these
nonhuman primates. Previous studies of this
rhesus macaque allergic airway disease model
showed immunological and structural
responses similar to those in human asthmatic
lungs (23, 24). The allergic monkey airways
displayed elevated eosinophil accumulation
in both proximal and distal airways, in
addition to an increased eosinophil presence
in the bronchoalveolar fluid. Furthermore,
extensive airway remodeling was observed.
These changes indicate that the expression
of growth factors and morphogens
instrumental in both airway development
and homeostasis may have been disturbed.
Here, we report the existence of a BMP
signaling gradient along the airways. We
further report that this signaling pattern
is altered during allergic airway disease
and provide evidence that eosinophils
can modulate BMP signaling in airway
epithelial cells.
Materials and Methods
Rhesus Macaque Allergic Airway
Exposure Model
Rhesus macaques (Macaca mulatta) were
chosen from the breeding colony at the
California National Primate Research
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Centre, University of California, Davis,
CA. All animal housing and care were in
compliance with the Institute of Laboratory
Animal Resources and the Association
for Assessment and Accreditation of
Laboratory Animal Care. House dust mite
allergen (HDMA) and ozone (O3) exposure
experiments were performed as described
previously (25–27). The Institute of Animal
Use and Care Committee reviewed and
approved experimental protocols prior to
commencement.
Immunofluorescence
After deparaffinization, rehydration, and
antigen retrieval on tissue sections, both
tissue and methanol-fixed cells were stained
as described previously (28). Primary
antibodies were phosphorylated using SMAD
(pSMAD)-1/5/8 (sc-12353-R; SantaCruz
Biotechnology, Santa Cruz, CA), BMP
receptor (BMPR) Ia (sc-20736; SantaCruz),
and proliferating cell nuclear antigen (PCNA)
(sc-7907; SantaCruz Biotechnology). An
isotype control was prepared for each section.
Images were captured using an Olympus
BX61 (Olympus, Center Valley, PA).
BMPRIa nuclear localization was quantified
using an Olympus FluorViewFV1000
confocal microscope.
Stereology
Using point and intercept counting on
a cycloid grid, the approximate abundance
of fluorescent cells per unit basal lamina
of the epithelium was quantified for each
section, as described previously (29). By
counting the number of positive cells per
unit volume of interstitial epithelium on
the fluorescent image (Vv) and the surface
area of basal lamina per unit volume
of interstitial epithelium (Sv) on the
corresponding differential interference
contrast (DIC) image, the number of
positive cells per unit area of basal lamina
was calculated (Vs). (P, number of points
counted; bl, basal lamina; epi, epithelium;
I, intersection; l/p, length/point, 86 mm;
txred, Alexa568 positive cells).
Vvtxred=epi ¼ Ptxred

Pepi1 Ptxred

Svbl=epi ¼ ½ðP3IblÞ=2
ðl=pÞ3Pepi

Vstxred=bl ¼ Vvtxred=epi

Svbl=epi
Quantification was carried out using the
Stereology Toolbox (Morphometrix,
University of California, Davis, CA).
Statistical analysis was calculated using one-
way analysis of variance tests and paired
two-tailed t test in GraphPad Prism version
5.00 (GraphPad, San Diego, CA). P, 0.05
was considered significant.
Air–Liquid Interface Differentiation
and Culture of Primary
Tracheobronchial Epithelium
Tracheal epithelial cells were harvested from
rhesus monkeys after necropsy as described
previously (30). Once the cells were
confluent and differentiated at the
air–liquid interface (ALI), BMP-4 (R&D
Systems, Oxan, UK) at 100 ng/ml was
administered apically. After 72 hours,
whole-cell protein was harvested as
outlined previously (28). Blots were probed
using pSMAD 1/5/8 antibody.
Isolation of Eosinophil-Derived
Proteins
Purified eosinophil proteins were a gift
from Dr. G. Gleich and were prepared as
described previously (31).
Isolation of Mouse Airway Epithelial
Cells and Coculture with Eosinophil-
Derived Proteins
Mouse airway epithelial cells (MAECs) were
isolated from female C3H-Hen mice as
described previously (32). For the eosinophil-
derived protein treatment, MAECs were
seeded onto fibronectin-coated chamber
slides overnight. Serum-free media containing
eosinophil-derived neurotoxin (EDN),
eosinophil peroxidase (EPO), or major basic
protein (MBP) at 0.5 mg/ml was added for
2, 17, or 48 hours and was maintained at
378C, 5% carbon dioxide. Cultures were washed
and fixed with methanol for immunostaining.
Results
pSMAD 1/5/8 Signaling Gradient in
Healthy Juvenile Rhesus Macaque
Airways
We hypothesized that a BMP signaling
gradient exists in healthy airways and
that this gradient may be altered during
inflammatory airway disease and
regeneration. To investigate this hypothesis,
we used immunofluorescence to examine
the expression of BMP signaling pathway
components in the airway epithelium of
healthy juvenile rhesus macaques aged 6
and 12 months that had been housed in
chambers supplied with filtered air. Tissue
sections from previous studies were used
for this study (23, 26). As outlined in
Figure 1, rhesus macaque models of
asthma and recovery were developed
previously. All monkeys in this study were
male. Group 1 monkeys were exposed to
filtered air for 6 months and served as
healthy control animals. Group 2 monkeys
were sensitized to HDMA allergen and
were housed in specialized air chambers
supplied with cyclic doses of aerosolized
HDMA and O3 for 5 months. These
monkeys developed asthma and were sent
to necropsy at 6 months old. A recovery
model, group 4, was also established
whereby monkeys were exposed to cyclic
doses of HDMA and O3 for 5 months
followed by 6 months of filtered air,
including one dose of aerosolized HDMA
per month. These monkeys were killed at
12 months old. Control animals, group 3,
were housed in filtered air for 12 months.
Tissue from the trachea of 6-month-old
monkeys was no longer available and so
could not be included in this study. We
chose to examine expression of BMPRIa as
an indicator of potential cell responsiveness
to BMP ligands. We used an antibody that
recognizes pSMADs 1, 5, and 8 to detect
nuclear localized SMADs as an indicator of
active BMP signaling. We also examined the
expression of PCNA as an indicator of
regeneration in the airway epithelium.
Immunofluorescence was performed
to examine PCNA, BMPRIa, and pSMAD
1/5/8 expression in lung tissue sections
from airway epithelium of healthy
6-month-old (group 1) and 12-monthold
(group 3) rhesus macaques (Figure 1A).
The volume of positively labeled epithelial
cells per unit basal lamina was counted
after randomized sampling of airway
sections. Expression of PCNA was
observed in the nuclei of epithelial cells
throughout the airways of these animals
(Figures 2A and 2B; see Figure E1 in
the online supplement). No significant
difference in the level of expression of
PCNA in the airways was detected in
either age group. Expression of BMPRIa
was observed in all regions examined, and
no significant difference in the expression
of membrane-bound BMPRIa in the
conducting airways and distal bronchioles
in 6- and 12-month-old monkeys was
detected (Figure 2). Expression of nuclear-
localized pSMAD 1/5/8 was also evident
throughout the airways of rhesus
macaques at both 6 and 12 months
old (Figure 2). In the 12-month-old
monkey group, the incidence of nuclear
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pSMAD 1/5/8 was significantly greater
in the trachea compared with either
the conducting airways or the distal
bronchioles (Figure 2B; P = 0.0023 and
0.0064, respectively). The unavailability
of tracheal tissue from the 6-month-old
cohort meant that pSMAD 1/5/8
expression could not be examined in these
tissues and there was no significant
difference in pSMAD 1/5/8 in conducting
airways compared with distal bronchioles
in this group.
Asthma model Recovery model
Age
2 days
14 days
28 days
30 days
6 months
7–11 months
Selected for the study
based on weight and
negative HDM skin
prick test
Selected for the study
based on weight and
negative HDM skin
prick test
sensitized to D. farniae
in alum + heat-killed
B. pertussis
sensitized to D. farniae
in alum + heat-killed
B. pertussis
11 cycle regimen
(see B)
NecropsyNecropsy
12 months Necropsy Necropsy
11 cycle regimen
(see B)
sensitized to D. farniae
in alum + heat-killed
B. pertussis
sensitized to D. farniae
in alum + heat-killed
B. pertussis
Selected for the study
based on weight and
negative HDM skin
prick test
Selected for the study
based on weight and
negative HDM skin
prick test
Group 1: Control Group 2: Treatment Group 3: Control Group 4: Treatment
FA
FA
FA
FA
FA
FA*
FA*
FA
FA
FA
A
Day 1
1 cycle
Filtered Air (FA)
Ozone (O3)
Aerosolized D. farinae (HDMA)
2 3 4 5 6 7 8 9 10 11 12 13 14
Trachea
Trachea Level 3, Level 5 Level 7
Conducting airways Distal bronchioles
B C
Figure 1. Experimental outline. (A) Animals were chosen for the study on the basis of a negative intradermal skin sensitivity test to Dermatophaoides
farinae, a common house dust mite allergen (HDMA). Male rhesus macaques were included in the study. At 14 days old, D. farinae in alum was injected
subcutaneously, in addition to an intramuscular injection of heat-killed Bortetella pertussis. At 28 days old, a repeated dose of D. farinae was given in alum.
When the rhesus macaques were 30 days old, they were moved to specially regulated air chambers. The asthma model cohort received 11 repeated
doses of ozone and aerosolized HDMA and were sent to necropsy at 6 months old, as outlined in B. In the recovery model, the monkeys received the
same cyclic exposure. After the 11th cycle, FA was supplied to the chambers for an additional 6 months. These monkeys underwent necropsy when
they were 12 months old. *HDMA1 ozone (O3) was given for 2 hours on a monthly basis to maintain sensitivity. (B) Aerosolized ozone was supplied
for 5 days (solid gray), with aerosolized HMDA (solid dark gray) on Days 3 to 5. FA was supplied subsequently for 9 days. This regimen was repeated 11 times.
Treatment lasted for 5 months. (C) The left cranial lobe was harvested, and the mainstem bronchus was dissected into consecutive sections for paraffin wax
embedding. For the purpose of this study, airway levels 3 and 5 were classified as the conducting airways with a ciliated pseudostratified columnar epithelium.
Airway level 7 sections were classified as distal bronchioles. The epithelial wall is made of simple ciliated columnar epithelium. FA, filtered air.
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Reduced Levels of Nuclear pSMAD
1/5/8 Expression in Conducting
Airways of Monkeys with Asthma
Repeat exposure of sensitized rhesus
macaques to HDMA/O3 was performed
over a 6-month period to induce allergic
airway disease as reported previously (23).
Immunofluorescence analysis was
performed on tissues from these 6-month-
old animals. No significant difference in
the expression levels of PCNA was detected
in 6-month-old animals with asthma
(Figure 2A; group 2) compared with
healthy control animals (group 1) at either
airway level examined (Figures 3A and 3B).
Similarly, no difference was detected in
expression levels of BMPRIa. However,
translocation of BMPRIa from the
membrane and cytoplasm to the nucleus
of some epithelial cells in the conducting
airways of animals with asthma was
observed (Figures 3D and E3). Levels of
nuclear pSMAD 1/5/8 were significantly
reduced in the conducting airways of
animals with asthma compared with
healthy animals (Figure 3C).
Increased Expression of PCNA,
BMPRIa, and pSMAD 1/5/8 in
Conducting Airways of Recovering
Lungs
After cyclic exposure to HDMA/O3 over
a 6-month period, a group of animals
was subsequently housed in chambers
supplied with filtered air for an additional
6 months to investigate the extent to which
recovery, if any, could occur after a chronic
lung injury, as reported previously (26).
Immunohistochemical analysis was
performed on tissues from these 12-month-
old animals. The expression of PCNA was
significantly elevated (P = 0.0013) in the
conducting airways of these animals
(Figure 1A; group 4) compared with
healthy animals (group 3) (Figure 4A).
The expression of BMPRIa and nuclear
SMAD 1/5/8 was also increased
significantly (P = 0.0037 and 0.045,
respectively) in the conducting airways of
recovering animals (Figures 4B–4D).
Primary Tracheobronchial Cells Are
Responsive to BMP-4 Ligand
Given the observation that pSMAD 1/5/8
is elevated in the epithelium of conducting
airways of recovering lungs, we sought to
investigate which specific BMP ligands
could be driving this increase in pathway
activation. Our laboratory has shown
previously that primary MAECs are
responsive to exogenous BMP-2, -4,
and -7 in vitro, and given that BMP-4 has
been reported in both healthy and diseased
airway tissue, we hypothesized that this
ligand may activate SMAD signaling in
rhesus macaque airway epithelial cells
(33, 34).
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Figure 2. Bone morphogenetic protein (BMP) expression gradients in healthy airways at 6 and 12 months. (A) Membrane-localized expression of
BMP receptor (BMPR) Ia and nuclear expression of proliferating cell nuclear antigen (PCNA) and phosphorylated SMAD (pSMAD) 1/5/8 were quantified
using stereologic techniques throughout the airways of healthy rhesus macaques. There was no significant difference in PCNA, BMPRIa, or pSMAD 1/5/8
expression in the epithelium of conducting airways and distal bronchioles in 6-month-old monkeys. (B) PCNA and BMPRIa expression was unchanged
along the airways of 12-month-old rhesus macaques. pSMAD 1/5/8 expression was significantly different in the tracheal epithelium of 12-month-old
monkeys compared with the conducting airways and distal bronchioles. n = 3 for all targets; **P, 0.005. VSTxred/bl, the number of positive cells per unit
volume of interstitial epithelium.
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Figure 3. Suppression of PCNA, BMPRIa, and pSMAD 1/5/8 in conducting airways of monkeys with active asthma. (A) No significant difference in PCNA
expression was detected in the airways of healthy rhesus macaques versus rhesus macaques with asthma. (B) There was no significant difference in
membrane-bound BMPRIa expression in the airways of healthy rhesus macaques versus rhesus macaques with asthma. (C) A significant decrease in nuclear
pSMAD 1/5/8 expression was evident in healthy monkeys versus monkeys with asthma. Immunofluorescent images were quantified using stereologic
techniques. n = 3 for all targets; **P, 0.005; FA = 6 months of FA; HDMA/ozone (O3) = 6 months of exposure to HDMA/O3. (D) BMPRIa immunofluorescent
images displayed nuclear localization in the epithelium of asthmatic conducting airways compared with healthy airways, as indicated by thewhite arrows (a–f).
Significant down-regulation of nuclear pSMAD 1/5/8 was seen in asthmatic conducting airways compared with healthy epithelium (g–l). Combined images of
Alexa568-stained targets and 4’,6-diamidino-2-phenylindole (DAPI) are shown (e, f, k, l). Scale bars represent 20 mm.
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Primary tracheobronchial epithelial
cells were harvested from healthy rhesus
macaques and grown in an ALI culture
system. After 72 hours of treatment with
BMP-4, levels of pSMAD 1/5/8 were
increased 1.5-fold (n = 3, P, 0.05) in
these cells (Figures 5A and 5B).
Nuclear Translocation of BMPRIa in
Primary MAECs Cocultured with
Eosinophils and Eosinophil-Derived
Proteins
We were interested in the observation of
nuclear translocation of BMPRIa in some
epithelial cells in the conducting airways
of 6-month-old animals with asthma.
Previous studies of this rhesus macaque
allergic airway disease model showed
immunological and structural responses
in the airways similar to those in human
asthmatic lungs with elevated eosinophil
accumulation in both proximal and distal
airways, in addition to an increased
eosinophil presence in the bronchoalveolar
fluid (23). Extensive airway remodeling was
also observed in these animals.
During inflammation, eosinophils
elicit their effector response in part by the
release of cytotoxic proteins such as EDN,
EPO, and MBP. Given that eosinophils-
derived proteins contribute to airway
hyperresponsiveness and remodeling in
inflammatory airways diseases and that BMP
ligands have been shown to colocalize with
MBP in asthmatic airways, we examined
whether these eosinophil-derived proteins
could modulate BMP signaling in epithelial
cells (34, 35). MAECs were used in culture on
the basis of the similarities between human
and murine eosinophilic responses (36).
MAECs were exposed to eosinophil-derived
proteins for 2, 17, or 48 hours and
BMPRIa expression was examined by
immunofluorescence (Figure 6). At 2 hours,
BMPRIa appeared localized to the cytoplasm.
However at 17 hours, nuclear localization
of BMPRIa was observed in 30, 56, and 36%
of MAECs exposed to EDN, EPO, MBP,
respectively. The translocation was transient,
however, because at 48 hours, BMPRIa was
localized primarily in the cytoplasm. Nuclear
localization was quantified at the 17-hour
time point (Figure 6B).
Discussion
Lung development relies on the complex
interplay of signaling pathways such as
those regulated by the BMP family. It is
believed that gradients of morphogens, such
as BMP-4, are critical in forming the lung
architecture as well as in directing the
spatial distribution of epithelial cells types
throughout the airways (9, 37). These
pathways are believed to be reactivated
in injured and diseased adult lungs to
orchestrate epithelial repair and to restore
healthy airway homeostasis. Our group
and others have shown that BMP signaling
is activated during repair in rodent
models of airway injury using ovalbumin,
nitronaphthalene, and bleomycin exposure
(28, 33, 38). Furthermore, BMP signaling
is activated in lung stem cell niches after
injury, highlighting the importance
of the BMP pathway in epithelial cell
differentiation and proliferation (39).
Studies of human bronchial biopsies
have also shown that BMPR expression is
attenuated in atopic patients with mild
asthma compared with control subjects and
that after allergen exposure, BMP pathway
activity is elevated, shown by increased
pSMAD 1/5/8 expression and BMP-7
ligand expression in the airway epithelium
(34). However, to date, the concept of
signaling gradients along the respiratory
axis has not been investigated in healthy
adult lungs.
In our study, the presence of nuclear
pSMAD 1/5/8 in the conducting airways
and distal bronchioles of healthy 6- and
12-month-old monkeys demonstrates
constitutive activation of BMP signaling in
these regions. Similar results have been
reported by us and others in rat and human
airway epithelium, although pSMAD 1/5/8
was reported absent from the bronchial
epithelium of phosphate-buffered
saline–treated mouse lungs (38, 39). In the
current study, we also detected a significant
gradient in nuclear pSMAD 1/5/8
localization in the distal airways of healthy
12-month-old nonhuman primates. This
suggests that BMP signaling may play a
role in the maintenance of homeostasis
throughout the airways and suggests a more
active role in the trachea compared with
the lower airways. Interestingly, BMPRIa
expression did not vary significantly
throughout the airways. This indicates that
positive regulators of BMP signaling, such
as BMP ligands themselves, may be more
active in the trachea, or that negative
regulators, such as noggin and gremlin,
may be more active in the lower airways.
We confirmed here that BMP-4 is capable
of signaling via SMADs in primary ALI
cultures of monkey tracheal epithelial cells.
The levels of nuclear PCNA in the airways
did not vary significantly, consistent with
health and homeostasis. BMP signaling is
involved in muscle, skeletal, and adipose
tissue homeostasis, and our results indicate
a role for BMP signaling in airway
homeostasis (40). Given that BMP signaling
governs cell cycle progression in vitro
and orchestrates correct epithelial cell
differentiation during lung morphogenesis,
we speculate that BMP signaling is involved
in epithelial cell turnover in healthy airways
and in mediating epithelial homeostasis
(9, 28, 33).
Repeat exposure of HDMA/O3 was
used to induce allergic airway disease in
the 6-month treatment group of rhesus
macaques. Previous studies of these
monkeys demonstrated both immune
and structural responses in the airways
(23, 24). The animals displayed elevated
eosinophil accumulation in both proximal
and distal airways and increased eosinophil
presence in bronchoalveolar fluid.
Furthermore, the lungs displayed extensive
remodeling, which directly affected the
functionality of the airways. Conducting
airways and terminal bronchioles exhibited
elevated mucous cell mass, and a negative
correlation between baseline airway
resistance and the ratio of conducting
airways to lung parenchyma was evident
(23). This suggests that the cyclic
exposure model causing allergic airway
disease alters the rudimental growth
factor and morphogen patterns that
orchestrate correct respiratory tract
repair and epithelial cell distribution. By
examining the expression profile of BMP
components along the airways, we have
shown that the normal BMP pathway
signals are indeed perturbed as a result
of HDMA/O3 exposure. A significant
decrease in nuclear pSMAD 1/5/8 in the
lung epithelium of conducting airways was
evident. Furthermore, although the results
proved not to be statistically significant,
a decreasing trend of BMPRIa expression
could be seen in epithelium of both the
conducting airways and the distal
bronchioles.
Interestingly, in addition to reduced
pSMAD 1/5/8, nuclear localization of
BMPRIa was evident in the conducting
airway epithelium of the 6-month asthma
group. Infiltrating eosinophils were shown
previously to be significantly elevated in the
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Figure 4. Elevated expression of PCNA, BMPRIa, and pSMAD 1/5/8 in conducting airways of recovering monkeys with asthma. (A) PCNA expression
was elevated in the conducting airways when a period of 6 months’ recovery in FA was provided after 6 months of exposure to HDMA and ozone (O3). (B)
Membrane-localized BMPRIa expression was elevated in the epithelium of the conducting airways of the recovery group of animals. (C) Nuclear pSMAD
1/5/8 expression was elevated in the epithelium of conducting airways in the recovery group of animals. Quantified immunofluorescence using stereologic
techniques is shown. n = 3 for all targets; *P, 0.05; **P, 0.005. FA = 12 months of FA; HDMA/O31 FA = 6 months of exposure to HDMA/O31
6 months of FA. (D) Representative immunofluorescent images display elevated membrane-localized BMPRIA expression in recovering airways (b)
compared with healthy airways (a). Images show an increase in nuclear pSMAD 1/5/8 in recovering airways (g) compared with those in healthy animals (h).
Combined images of Alexa568-stained targets and DAPI are shown (e, f, k, l). Scale bars represent 20 mm.
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conducting airways and distal bronchioles of
these monkeys, and we hypothesized a link
between these inflammatory cells and the
BMP pathway. Many studies have shown
that eosinophils, and specifically their
secondary derived proteins, play a central
role in airway remodeling, perpetuating
airway hyperresponsiveness in asthma and
inflammatory airway diseases, but the
signaling pathways governing these events
remain poorly understood (41–43). Our
results using primary MAECs indicate
a possible mechanism whereby the
eosinophil-derived proteins may influence
BMP signaling by altering the localization
of BMPRIa. Moreover, if reduced pSMAD
1/5/8 signaling is a consequence of this
modulation, this could explain the
significant reduction in levels of nuclear
pSMAD 1/5/8 in the conducting airways in
the 6-month asthma group. This possibility
is further supported by Kariyawasam
and colleagues, who demonstrated that
eosinophils are the predominate producer
of BMP-7 in the lung epithelium of
asthmatic airways (34). Colocalization of
BMP-7 with MBP-positive eosinophils
was observed in these asthmatic airways.
Because BMP-7 is known to act as an
antiinflammatory ligand in other organs,
the authors speculated that the increase in
ligand expression could be an attempt to
regulate inflammation as part of the
reparative processes in the airways (34, 44).
In addition, an in vitro study using the
neuroblast IMR32 cell line reported a
similar down-regulation of BMPRIa gene
expression after a 4-hour exposure to
eosinophil-derived MBP. Furthermore,
coincubation of the cells with BMP-7 and
MBP decreased the induction of inhibitor
of differentiation (ID)-1, an established
downstream target of the BMP pathway
(42). Taken together with our results, we
hypothesize that the attenuated expression
levels of BMP signaling present in this
nonhuman primate model of asthma are
caused by eosinophil-induced nuclear
translocation of membrane-bound
BMPRIa. Subsequent inhibition of
downstream BMP signaling pathways
interferes with the appropriate epithelial
repair processes mediated by BMP and its
signaling partners such as fibroblast growth
factor 7 (45). This could contribute to a
chronic disease state promoting incorrect
epithelial turnover, an inflammatory
phenotype, and epithelial remodeling, all
of which are well-established hallmarks of
asthma. Although BMPR processing and
trafficking between the nucleus and the
membrane are essential for correct signal
transduction, incorrect receptor trafficking
can contribute to disease, as evidenced
by BMPRII mutations in pulmonary
hypertension (46, 47). Our results highlight
a potential novel mechanistic relationship
between the granule proteins secreted by
eosinophils and BMPRIa trafficking in
asthma.
The regenerating airway model
used here provided further evidence for
the involvement of BMP signaling in
inflammatory airway disease and repair
processes. The increased incidence of
nuclear PCNA is consistent with repair
processes in the conducting airways after a
period of chronic injury and inflammation.
Increased expression of membrane-
localized BMPRIa in these regions indicates
a role for BMP signaling in the repair/
regeneration processes. In other mouse and
human asthma models, similar increases
in BMP signaling evidenced by nuclear
pSMAD1/5/8 were observed in bronchial
epithelium challenged with ovalbumin or an
aeroallergen, respectively (34, 38). Previous
studies of this rhesus macaque model
showed that these monkeys displayed
modest signs of repair and airway
regeneration. Perlecan was reintroduced at
the basement membrane and there was
evidence for the reestablishment of correct
mucous cell expression in the proximal
airways (48). We speculate that this
recovering phenotype of the airways
is further promoted by increased BMPRIa
expression at the membrane, promoting
elevated ligand-induced nuclear translocation
of pSMAD 1/5/8 protein. This causes the
epithelial cells to enter a state of active repair
and differentiation in an attempt to restore
an appropriate homeostatic environment in
the airways. This occurs perhaps through
the expression of ID genes and elevated
production of BMP-7 ligand in an attempt to
counteract the antimitogenic properties of
transforming growth factor-b to regulate cell
proliferation, remodeling, and epithelial
differentiation (49, 50).
Conclusions
We speculate that the higher BMPRIa
membrane staining in the recovery
monkeys is a result of reduced eosinophil
infiltration in the airways. This is
supported by previous human asthmatic
airway studies that showed attenuated
cellular inflammation after the removal of
airway insult and a reduced eosinophil
presence in the BAL fluid of the
recovery monkeys compared with the
monkeys with asthma (Figure E4) (51).
Lowered levels of eosinophilic
granule proteins could decrease the
nuclear translocation of BMPRIa and thus
account for the elevated membrane-
localized BMPRIa expression and nuclear
pSMAD 1/5/8 signaling seen in the cells.
As a result, an important feedback
mechanism in the lung epithelium may
exist whereby the removal of airway
insult reduces eosinophil infiltration and
eosinophil-induced down-regulation of
BMP signaling. This hypothesis is
supported by recent studies showing for
the first time a definitive antiinflammatory
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Figure 5. Primary monkey tracheobronchial epithelial cells are responsive to BMP-4 ligand
stimulation. (A) Western blot of primary tracheobronchial epithelial cells differentiated at air–liquid
interface and subsequently stimulated with 100 ng/ml BMP-4 for 74 hours showed elevated
pSMAD 1/5/8 expression. (B) Densitometry analysis of the blots showed that pSMAD 1/5/8
expression was increased z2.1-fold after treatment with BMP-4, compared with control cells.
Cultures were performed with epithelial cells isolated from three individual rhesus macaque monkeys.
*P , 0.05.
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function of BMP signaling in the stomach
and airway epithelium (52, 53). The
enhanced BMP pathway activity could
induce the putative antiinflammatory
function of BMPs, preventing further
inflammation and damage to the
epithelium and facilitating the
restoration of correct epithelial cell
turnover and repair. Our work using this
nonhuman primate model of allergic
airway disease supports this hypothesis
and furthermore, our results suggest that
not only are developmental pathways
reactivated during inflammatory airway
disease involving epithelial injury, but
that basal expression of the BMP
signaling pathway may be important for
maintaining healthy airways. n
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Figure 6. BMPRIa nuclear translocation in mouse airway epithelial cells (MAECs) treated with eosinophil derived granule proteins. (A) MAECs were
exposed to human eosinophil-derived proteins over a time course of 2, 17, and 48 hours. BMPRIa appeared localized to the cytoplasm of untreated cells
at 2, 17, and 48 hours. At 2 hours, BMPRIa was localized to the cytoplasm of MAECs exposed to eosinophil-derived neurotoxin (EDN), eosinophil
peroxidase (EPO), or major basic protein (MBP) at a concentration of 0.5 mg/ml (a–h). At 17 hours, BMPRIa was localized to the nuclei of cells exposed to
0.5 mg/ml EDN, EPO, and MBP (i–p). BMPRIa was relocalized to the cytoplasm with no nuclear localization apparent after 48 hours of exposure to EDN,
EPO, and MBP. Arrows denote BMPRIa nuclear localization (q–x). Scale bars represent 50 mm. (B) BMPRIa nuclear localization was quantified by counting
positively immunostained nuclei. Graph illustrates mean expression of BMPRIa in 30, 56, or 36% of MAECs with exposure to EDN, EPO, or MBP,
respectively. Results are representative of counts obtained from three separate experiments. Approximately 800 cells were counted in at least three fields
of view. Cells were counterstained with DAPI. *P, 0.05; ***P, 0.0005 after Student t test.
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